STOCK FOCUS OF THE DAY
Heineken Malaysia : Results chug along BUY
We maintain our BUY recommendation with an unchanged
DCF-derived fair value of RM19.80/share on Heineken Malaysia Bhd (HEIM). We
leave our earnings forecast unchanged while introducing FY19F projections. We
like HEIM for highly defensive earnings properties and its attractive dividend
yields of 5.7-6.6% for FY17F-FY19F. HEIM recorded a 4QFY16 net profit of
RM104.7mil (QoQ: 55.4%, YoY: 15.2%) bringing FY16 net profit to RM1,880mil
(YoY: 6.6%). HEIM’s results key highlights included:- (1) Topline for the quarter
grew by 10.1% YoY on the back of purchases tied to CNY spending. Better brand
mix skewed towards HEIM’s premium brands, Heineken and Guinness boosted overall
ASPs. While the better brand mix is neutral to earnings, we are pleasantly
surprised over this development as it may be indicative of consumer spending
displaying greater resilience than initially thought. (2) 4Q saw a favourable
timing of capital adjustments, lowering overall FY16’s effective tax rate to
21.3% (vs. our assumption of 26.4%). Excluding the deviation, earnings would
have fallen in line with expectations.
We expect ASPs to remain unchanged given the constraints
arising from recently adjusted Price Control Anti-Profiteering Act on F&B
operators. Recall that ASPs were upward adjusted by 3-5% as recently as FY16
following the revision in alcohol excise duty in Mar 2016. Management expects
the integration to Heineken International and as a result, access to global
procurement to alleviate rising input costs. Consequently, we expect overall
margins to hold steady as other operational efficiencies are expected to be
realised. Key risk to our forecast includes unfavourable outcome of unresolved
bills of demand with the Royal Malaysian Customs amounting to RM56.3mil or 20%
of FY17F earnings. HEIM’s strong free cash flows and low net gearing level of
20% should hold it in good stead to sustain dividends.
Others :
UMW Holdings : Better times are
coming
HOLD
STOCKS ON THE RADAR
Yong Tai,Gabungan AQRS,Tadmax Resources,My E.G.Services
ECONOMIC HIGHLIGHTS
US : Looking at two rate hikes
NEWS HIGHLIGHTS
Malakoff Corp : EPF sells 6m Malakoff shares since early Feb
Manufacturing Sector : EG Industries to raise nearly RM64m
from rights issue
Healthcare Sector : CCM DBio, PanGen set to launch
biosimilars for kidney dialysis
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.